cysteamine has been researched along with Dry Eye in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Giancarlo, I; Gianni, P; Luca, B; Maria, SC; Matteo, F; Parrilla, R; Sergio, P; Valente, P | 1 |
| Cho, SH; Cho, SW; Choi, SY; Eum, WS; Hwang, HS; Kim, DW; Ku, SK; Kwon, OS; Lee, SH; Park, J; Yoon, GH | 1 |
2 other study(ies) available for cysteamine and Dry Eye
| Article | Year |
|---|---|
Analysis of tear film in cystinosis patients treated with topical viscous cysteamine hydrochloride (Cystadrops
Topics: Cornea; Cysteamine; Cystinosis; Dry Eye Syndromes; Humans; Osmolar Concentration; Reproducibility of Results; Tears | 2022 |
Transduced PEP-1-FK506BP ameliorates corneal injury in Botulinum toxin A-induced dry eye mouse model.
Topics: Administration, Topical; Animals; Botulinum Toxins, Type A; Cell Line; Conjunctiva; Cornea; Cysteamine; Disease Models, Animal; Dry Eye Syndromes; Immunohistochemistry; Interleukin-1beta; Macrophage Inflammatory Proteins; Mice; Peptides; Recombinant Fusion Proteins; Tacrolimus Binding Proteins; Transduction, Genetic; Tumor Necrosis Factor-alpha | 2013 |